So-Young International Inc.
HealthcareNASDAQ:SY · NASDAQ Global Market
-$0.11 today
Vol 0.74M · Avg 0.62M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-15.2%
avg -13.2%
ROIC
-13.0%
avg -11.3%
ROA
-8.9%
avg -7.3%
Analysis
ROA is currently the strongest return metric at -8.9% versus its period average of -7.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Gefei Li | Chief Operating Officer & Director | — | — | 31 | $0.00 | <0.01% |
Mona Qiao | Investor Relations Officer | — | — | — | — | — |
Bei Wang | Chief Marketing Officer & Director | — | — | 40 | $0.00 | <0.01% |
Christian Arnell | Investor Relations Officer | — | — | — | — | — |
Vivian | Investor Relations Officer | — | — | — | — | — |
Tao Yu | Co-Founder & Consultant | — | — | 47 | — | — |
Xing Jin | Co-Founder, CEO, Interim CFO & Chairman | — | — | 46 | $12.00M | 9.15% |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A0 analysts |
| Revenue | N/A | N/A | +70.9% | +19.0% (9yr)1 analysts |
| Net Income | N/A | N/A | -30.4% | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +70.9% over three years. Forward estimates point to Revenue at +19.0% (9yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
$852.86M
Cullinan Therapeutics, Inc.
NASDAQ:CGEM
$841.97M
Sonida Senior Living, Inc.
NYSE:SNDA
$700.96M
Omeros Corporation
NASDAQ:OMER
$632.20M
Varex Imaging Corporation
NASDAQ:VREX
$464.78M
SOPHiA GENETICS S.A.
NASDAQ:SOPH
$349.74M
Standard BioTools Inc.
NASDAQ:LAB
$346.53M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$329.81M
Simulations Plus, Inc.
NASDAQ:SLP
$329.75M
ADC Therapeutics S.A.
NYSE:ADCT
$133.55M
Who manages SY?
So-Young International Inc. (SY) lists 7 active executives. The top listed executive is Gefei Li, Chief Operating Officer & Director.
Are SY insiders buying or selling?
Recent insider activity shows net selling of $47.90M.
Explore More
Continue the stock analysis
Jump to another research area for this company.